The forecasted sales range of $112M-$116M by Xtant Medical for FY2024 is very close to the consensus estimate of $115.95M, suggesting that the company's financial performance is in line with market expectations. This alignment typically indicates a neutral impact on the stock price in the short term, as there are no significant positive or negative surprises.